Literature DB >> 22295148

Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers.

Nicola J Lomas1, Keira L Watts, Khondoker M Akram, Nicholas R Forsyth, Monica A Spiteri.   

Abstract

AIM: This study explored the cellular and biological interrelationships involved in Idiopathic Pulmonary Fibrosis (IPF) lung tissue remodelling using immunohistochemical analysis. METHODS AND
RESULTS: IPF and control lung tissues were examined for localisation of Epithelial Mesenchymal Transition (EMT), proliferation and growth factor markers assessing their relationship to key histological aberrations. E-cadherin was expressed in IPF and control (Alveolar type II) ATII cells (>75%). In IPF, mean expression of N-cadherin was scanty (<10%): however 4 cases demonstrated augmented expression in ATII cells correlating to histological disease status (Pearson correlation score 0.557). Twist was expressed within fibroblastic foci but not in ATII cells. Transforming Growth Factor- β (TGF-β) protein expression was significantly increased in IPF ATII cells with variable expression within fibroblastic foci. Antigen Ki-67 was observed within hyperplastic ATII cells but not in cells overlying foci. Collagen I and α-smooth muscle actin (α-SMA) were strongly expressed within fibroblastic foci (>75%); cytoplasmic collagen I in ATII cells was present in 3 IPF cases. IPF ATII cells demonstrated variable Surfactant Protein-C (SP-C).
CONCLUSIONS: The pathogenesis of IPF is complex and involves multiple factors, possibly including EMT. Histological analysis suggests TGF-β-stimulated myofib rob lasts initiate a contractile response within established fibroblastic foci while proliferating ATII cells attempt to instigate alveolar epithelium repair. Marker expression (N-cadherin and Ki-67) correlation with histological disease activity (as reflected by fibroblastic foci extent) may emerge as future prognostic indicators for IPF.

Entities:  

Keywords:  Idiopathic Pulmonary Fibrosis; epithelial-mesenchymal transition; immunohistochemistry; prognostic markers; tissue repair and remodelling

Mesh:

Year:  2012        PMID: 22295148      PMCID: PMC3267487     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  37 in total

1.  The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.

Authors:  Andrew G Nicholson; Laura G Fulford; Thomas V Colby; Roland M du Bois; David M Hansell; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

2.  Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.

Authors:  Yasushi Shintani; Masato Maeda; Nina Chaika; Keith R Johnson; Margaret J Wheelock
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

3.  Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells.

Authors:  Jörn Bullwinkel; Bettina Baron-Lühr; Anja Lüdemann; Claudia Wohlenberg; Johannes Gerdes; Thomas Scholzen
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

Review 4.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

5.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63.

Authors:  Marco Chilosi; Venerino Poletti; Bruno Murer; Maurizio Lestani; Alessandra Cancellieri; Licia Montagna; Paola Piccoli; Giulia Cangi; Gianpietro Semenzato; Claudio Doglioni
Journal:  Lab Invest       Date:  2002-10       Impact factor: 5.662

7.  Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

Authors:  T E King; M I Schwarz; K Brown; J A Tooze; T V Colby; J A Waldron; A Flint; W Thurlbeck; R M Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

8.  The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.

Authors:  Mark D Sides; Ross C Klingsberg; Bin Shan; Kristin A Gordon; Hong T Nguyen; Zhen Lin; Takashi Takahashi; Erik K Flemington; Joseph A Lasky
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-06       Impact factor: 6.914

9.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  J Gribbin; R B Hubbard; I Le Jeune; C J P Smith; J West; L J Tata
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

10.  Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung.

Authors:  L Zhou; L Lim; R H Costa; J A Whitsett
Journal:  J Histochem Cytochem       Date:  1996-10       Impact factor: 2.479

View more
  44 in total

1.  Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.

Authors:  Guang-Sheng Lei; Hannah L Kline; Chao-Hung Lee; David S Wilkes; Chen Zhang
Journal:  Am J Pathol       Date:  2016-07-05       Impact factor: 4.307

2.  Transforming growth factor-β1 regulates epithelial-mesenchymal transition in association with cancer stem-like cells in a breast cancer cell line.

Authors:  Yongfeng Jia; Di Wu; Fen Yun; Lin Shi; Nianrong Luo; Zhiyue Liu; Yonghong Shi; Qinnuan Sun; Lili Jiang; Shiqi Wang; Maolin Du
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Authors:  Jeremy Herrera; Colleen Forster; Thomas Pengo; Angeles Montero; Joe Swift; Martin A Schwartz; Craig A Henke; Peter B Bitterman
Journal:  JCI Insight       Date:  2019-01-10

4.  Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium.

Authors:  Ross Summer; Hoora Shaghaghi; DeLeila Schriner; Willy Roque; Dominic Sales; Karina Cuevas-Mora; Vilas Desai; Alok Bhushan; Maria I Ramirez; Freddy Romero
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

5.  Cadmium stimulates myofibroblast differentiation and mouse lung fibrosis.

Authors:  Xin Hu; Jolyn Fernandes; Dean P Jones; Young-Mi Go
Journal:  Toxicology       Date:  2017-03-21       Impact factor: 4.221

6.  Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.

Authors:  Nicola Ronan; Deirdre M Bennett; Kashif A Khan; Yvonne McCarthy; Darren Dahly; Louise Bourke; Adeline Chelliah; Alberto Cavazza; Kevin O'Regan; Fiachra Moloney; Barry J Plant; Michael T Henry
Journal:  Lung       Date:  2018-07-31       Impact factor: 2.584

7.  Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Authors:  Ryota Kanemaru; Fumiyuki Takahashi; Motoyasu Kato; Yoichiro Mitsuishi; Ken Tajima; Hiroaki Ihara; Moulid Hidayat; Aditya Wirawan; Yoshika Koinuma; Daisuke Hayakawa; Shigehiro Yagishita; Ryo Ko; Tadashi Sato; Norihiro Harada; Yuzo Kodama; Fariz Nurwidya; Shinichi Sasaki; Shin-Ichiro Niwa; Kazuhisa Takahashi
Journal:  Lung       Date:  2018-06-20       Impact factor: 2.584

Review 8.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

9.  Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

Authors:  Khondoker M Akram; Nicola J Lomas; Nicholas R Forsyth; Monica A Spiteri
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 10.  Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.

Authors:  Marissa J Schafer; Andrew J Haak; Daniel J Tschumperlin; Nathan K LeBrasseur
Journal:  Curr Rheumatol Rep       Date:  2018-01-26       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.